
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Biopharmaceutical Research Company
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The partnership with BRC, supports the study of Delta-9 THC products and formulations, allowing OBX to identify the phase appropriate, optimal products for formulations including Delta-9-tetrahydrocannabinol.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
June 14, 2022
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Biopharmaceutical Research Company
Deal Size : Undisclosed
Deal Type : Collaboration
